Suppr超能文献

脑内信号小体:在某些神经病理学(如阿尔茨海默病)发展中的相关性。

Signalosomes in the brain: relevance in the development of certain neuropathologies such as Alzheimer's disease.

机构信息

Laboratory of Cellular Neurobiology, Department of Physiology, School of Medicine, La Laguna University Tenerife, Spain.

出版信息

Front Physiol. 2011 Jun 3;2:23. doi: 10.3389/fphys.2011.00023. eCollection 2011.

Abstract

Emerging data suggest that compartmentalization of signaling molecules into particular membrane compartments, or lipid rafts, may be at the basis of numerous activities related to neuronal preservation against different pathologies. These signaling platforms (signalosomes) are formed by complex lipid and protein that may interact to develop a plethora of different physiological responses upon activation by different extracellular stimuli, thereby contributing to neuroprotection. One of the first studied signalosomes involved in neuroprotection against Alzheimer's disease (AD) is constituted by estrogen receptor (ER), in association with scaffolding caveolin-1 and a voltage-dependent anion channel (VDAC). In this complex, ER plays a neuroprotective role partially through the modulation of VDAC activation, a porin involved in amyloid-beta-induced toxicity. Interestingly, ER and VDAC interactions appear to be altered in lipid rafts of AD brains, a phenomenon that may contribute to neuronal impairment. Alterations in lipid components of these subdomains may contribute to destabilization of this macrocomplex. These recent advances in the relevance of signaling platforms related to brain preservation, in particular against AD, are discussed in this work.

摘要

新出现的数据表明,信号分子在特定膜隔室(或脂质筏)中的分隔可能是许多与神经元保护免受不同病理相关的活动的基础。这些信号平台(信号体)由复杂的脂质和蛋白质组成,它们可能相互作用,在受到不同细胞外刺激激活后,产生大量不同的生理反应,从而有助于神经保护。最早研究的与阿尔茨海默病(AD)神经保护相关的信号体之一是由雌激素受体(ER)组成,与支架蛋白 caveolin-1 和电压依赖性阴离子通道(VDAC)相关联。在这个复合物中,ER 通过调节 VDAC 的激活发挥神经保护作用,VDAC 是一种参与淀粉样β诱导毒性的孔蛋白。有趣的是,ER 和 VDAC 的相互作用似乎在 AD 大脑的脂质筏中发生了改变,这种现象可能导致神经元损伤。这些亚域的脂质成分的改变可能导致这个大分子复合物的不稳定。本文讨论了与大脑保护相关的信号平台(特别是针对 AD)的这些新进展的相关性。

相似文献

1
Signalosomes in the brain: relevance in the development of certain neuropathologies such as Alzheimer's disease.
Front Physiol. 2011 Jun 3;2:23. doi: 10.3389/fphys.2011.00023. eCollection 2011.
2
Estrogen Interactions With Lipid Rafts Related to Neuroprotection. Impact of Brain Ageing and Menopause.
Front Neurosci. 2018 Mar 6;12:128. doi: 10.3389/fnins.2018.00128. eCollection 2018.
3
Membrane-initiated signaling of estrogen related to neuroprotection. "Social networks" are required.
Horm Mol Biol Clin Investig. 2011 Oct 1;7(3):393-401. doi: 10.1515/HMBCI.2011.109.
4
Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease.
Neuroscience. 2014 Oct 10;278:354-66. doi: 10.1016/j.neuroscience.2014.07.079. Epub 2014 Aug 26.
8
Estrogen receptors in lipid raft signalling complexes for neuroprotection.
Front Biosci (Elite Ed). 2012 Jan 1;4(4):1420-33. doi: 10.2741/471.
9
Lipid raft ER signalosome malfunctions in menopause and Alzheimer's disease.
Front Biosci (Schol Ed). 2017 Jan 1;9(1):111-126. doi: 10.2741/s476.
10
VDAC and ERalpha interaction in caveolae from human cortex is altered in Alzheimer's disease.
Mol Cell Neurosci. 2009 Nov;42(3):172-83. doi: 10.1016/j.mcn.2009.07.001. Epub 2009 Jul 10.

引用本文的文献

1
Expression and function of estrogen receptors and estrogen-related receptors in the brain and their association with Alzheimer's disease.
Front Endocrinol (Lausanne). 2023 Jul 4;14:1220150. doi: 10.3389/fendo.2023.1220150. eCollection 2023.
6
The Critical Period for Neuroprotection by Estrogen Replacement Therapy and the Potential Underlying Mechanisms.
Curr Neuropharmacol. 2020;18(6):485-500. doi: 10.2174/1570159X18666200123165652.
7
Estrogen Interactions With Lipid Rafts Related to Neuroprotection. Impact of Brain Ageing and Menopause.
Front Neurosci. 2018 Mar 6;12:128. doi: 10.3389/fnins.2018.00128. eCollection 2018.
8
Impact of estrogens and estrogen receptor-α in brain lipid metabolism.
Am J Physiol Endocrinol Metab. 2018 Jul 1;315(1):E7-E14. doi: 10.1152/ajpendo.00473.2017. Epub 2018 Mar 6.
9
Amyloid-β Receptors: The Good, the Bad, and the Prion Protein.
J Biol Chem. 2016 Feb 12;291(7):3174-83. doi: 10.1074/jbc.R115.702704. Epub 2015 Dec 30.

本文引用的文献

2
Lipid Rafts: Linking Alzheimer's Amyloid-β Production, Aggregation, and Toxicity at Neuronal Membranes.
Int J Alzheimers Dis. 2010 Dec 27;2011:603052. doi: 10.4061/2011/603052.
4
Revitalizing membrane rafts: new tools and insights.
Nat Rev Mol Cell Biol. 2010 Oct;11(10):688-99. doi: 10.1038/nrm2977.
6
Cholesterol, Alzheimer's disease, prion disorders: a ménage à trois?
Curr Drug Targets. 2010 Aug;11(8):1018-31. doi: 10.2174/138945010791591386.
7
Lipid rafts: keys to neurodegeneration.
Brain Res Bull. 2010 Apr 29;82(1-2):7-17. doi: 10.1016/j.brainresbull.2010.02.013. Epub 2010 Mar 3.
8
Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex.
J Alzheimers Dis. 2010;19(2):489-502. doi: 10.3233/JAD-2010-1242.
10
VDAC and ERalpha interaction in caveolae from human cortex is altered in Alzheimer's disease.
Mol Cell Neurosci. 2009 Nov;42(3):172-83. doi: 10.1016/j.mcn.2009.07.001. Epub 2009 Jul 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验